Patient-centered care of de Quervain’s disease
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
To test the hypothesis that most patients that elect symptomatic treatment of de Quervain’s disease experience symptom resolution.
Materials and methods
Eighty-three of 314 (26%) patients that elected initial symptomatic treatment of de Quervain’s disease responded to a mail survey inquiring about symptom resolution, symptom duration, subsequent opinions and treatments, final impressions and comments.
Seventy-five respondents (90.4%) reported resolution of the pain, including 58 of the 61 (95%) respondents that elected neither corticosteroid injection nor surgery. Among patients with symptom resolution without injection or surgery 48 of 58 (83%) recalled symptoms for fewer than 12 months. The differences in reported average time to symptom resolution were not statistically significant between patients that elected or did not elect a corticosteroid injection.
Considered in the light of important limitations of this data including the reliance on patient recall and the limited response rate to the survey, the data are still intriguing. At least in one surgeon’s practice, most informed patients initially elect symptomatic treatment, and most experience symptom resolution within one year.
- Christie BG (1955) Local hydrocortisone in de Quervain’s disease. BMJ 1(4929):1501–1503 CrossRef
- Piver JD, Raney RB (1952) De Quervain’s tendovaginitis. Am J Surg Mar 83(5):691–694 CrossRef
- Lamphier TA, Long NG, Dennehy T (1953) De Quervain’s disease: an analysis of 52 cases. Ann Surg Dec 13 8(6):832–841
- McKenzie JM (1972) Conservative treatment of de Quervain’s disease. Br Med J Dec 16 4(5841):659–660
- Sawaizumi T, Nanno M, Ito H (2007) De Quervain’s disease: efficacy of intra-sheath triamcinolone injection. Int Orthop Apr 31(2):265–268 CrossRef
- Capasso G, Testa V, Maffulli N et al. (2002) Surgical release of de Quervain’s stenosing tenosynovitis postpartum: can it wait? Int Orthop 26(1):23–25 CrossRef
- Avci S, Yilmaz C, Sayli U (2002) Comparison of nonsurgical treatment measures for de Quervain’s disease of pregnancy and lactation. J Hand Surg [Am] Mar 27(2):322–324 CrossRef
- Sakai N (2002) Selective corticosteroid injection into the extensor pollicis brevis tenosynovium for de Quervain’s disease. Orthopedics Jan 25(1):68–70
- Rankin ME, Rankin EA (1998) Injection therapy for management of stenosing tenosynovitis (de Quervain’s disease) of the wrist. J Natl Med Assoc Aug 90(8):474–476
- Zingas C, Failla JM, Van Holsbeeck M (1998) Injection accuracy and clinical relief of de Quervain’s tendinitis. J Hand Surg [Am] Jan 23(1):89–96 CrossRef
- Weiss AP, Akelman E, Tabatabai M (1994) Treatment of de Quervain’s disease. J Hand Surg [Am] Jul 19(4):595–598 CrossRef
- Anderson BC, Manthey R, Brouns MC (1991) Treatment of De Quervain’s tenosynovitis with corticosteroids. A prospective study of the response to local injection. Arthritis Rheum Jul 34(7):793–798 CrossRef
- Richie CA 3rd, Briner WW Jr (2003) Corticosteroid injection for treatment of de Quervain’s tenosynovitis: a pooled quantitative literature evaluation. J Am Board Fam Pract Mar–Apr 16(2):102–106 CrossRef
- Lane LB, Boretz RS, Stuchin SA (2001) Treatment of de Quervain’s disease:role of conservative management. J Hand Surg [Br] Jun 26(3):258–260 CrossRef
- Patient-centered care of de Quervain’s disease
Journal of Hand and Microsurgery
Volume 1, Issue 2 , pp 68-71
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- DeQuervain’s syndrome
- patient-centered care
- shared decision making